Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Income from Continuing Operations (2018 - 2025)

Dna X filings provide 8 years of Income from Continuing Operations readings, the most recent being 3454000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 61.3% to 3454000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 8316000.0, a 167.48% decrease, with the full-year FY2025 number at 7955000.0, down 155.87% from a year prior.
  • Income from Continuing Operations hit 3454000.0 in Q4 2025 for Dna X, up from 4753000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 12843000.0 in Q4 2022 to a low of 11722000.0 in Q4 2021.
  • Median Income from Continuing Operations over the past 5 years was 2709000.0 (2024), compared with a mean of 2513900.0.
  • The widest YoY moves for Income from Continuing Operations: up 793.47% in 2024, down 1399.8% in 2024.
  • Dna X's Income from Continuing Operations stood at 11722000.0 in 2021, then surged by 209.56% to 12843000.0 in 2022, then plummeted by 110.02% to 1287000.0 in 2023, then skyrocketed by 793.47% to 8925000.0 in 2024, then crashed by 61.3% to 3454000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 3454000.0 (Q4 2025), 4753000.0 (Q3 2025), and 7475000.0 (Q2 2025) per Business Quant data.